Supporting Organizations:
Home  •  Conference Agenda  •  Symposium Agenda  •  Sponsors  •  Supporting & media  •  venue
sponsorship opportunities  •  Registration  •  Infocast
Gold Sponsor
Silver Sponsors
Bronze Sponsors
Media Partners
Congressman Mike Rogers
to deliver Keynote Address!

About the Event:

The threat of a significant influenza pandemic looms. In late 2005, President Bush outlined his $7B plan to prepare for a pandemic. The money is now being released to industry. On March 4, 2006, the Department of Health and Human Services awarded over $1B in contracts to five biopharmaceutical companies to drive new flu vaccine technologies. As a consequence, expectations for the country's pandemic preparedness are rising rapidly. However, delivering on pandemic influenza preparedness will require many additional steps, and the path forward is not yet clear.

End-to-End Preparedness for Pandemic Influenza: Opportunities for Public-Private Collaboration will bring together senior government officials and top industry executives to explore how an effective partnership between government and industry can be developed to tackle the next critical steps in delivering on public health preparedness for pandemic influenza. From development to production to supply to administration, these key leaders will examine each step in preparedness to identify the opportunities for strengthening government and industry collaboration and to address the underlying capabilities that must be in place to ensure success.

The event also includes the pre-conference Symposium, Supply Chain Readiness for Pandemic Influenza Response, where speakers representing the three major components of the pandemic response supply chain-production, supply, and administration-will focus on the integration and coordination of key components in the supply chain, highlight any gaps that may exist, and explore strategies for addressing those gaps.


The Honorable Mike Rogers
Congressman (R-MI)

Featured Speakers:

Anne Schuchat, M.D.
Rear Admiral, United States Public Health Service; Assistant Surgeon General; Director, National Center for Immunization and Respiratory Diseases (proposed)

Franz Kracher,
Project Officer,
Health Threats, DG Health
and Consumer Protection,
Director C Public Health
and Risk Assessment,


Participating Companies

ASD Healthcare

Baxter Vaccines

Centers for Disease Control and Prevention (CDC)

Cardinal Health, Inc.

Cornell University

DC Department of Health

Department of Health & Human Services (DHHS)

FFF Enterprises, Inc.

ImmuneRegen BioSciences, Inc.

Implicit Bioscience Pty. Ltd.

McKenna Long & Aldridge

MedImmune, Inc.

Novavax Inc.

PRTM Management Consultants

Punk, Ziegel & Company


Sanofi Pasteur SA

Solvay Pharmaceuticals B.V.

U.S. Food and Drug Administration (FDA)